FACSLyric Flow Cytometry System
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N98026Q00904 in this department, oldest first.
- Jul 29, 2026 · this noticePre-solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Authority: FAR 6.302-1 � Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements Contracting Activity: National Cancer Institute Proposed Contractor: Becton, Dickinson and Company (BD) Description of Requirement: FACSLyric Flow Cytometry System Justification for Sole Source: NCI intends to negotiate and award a sole source contract to BD Biosciences pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. BD Biosciences is the original manufacturer and exclusive source for the BD FACSLyric Fl… (show all)
ow Cytometer package, including its proprietary hardware, firmware, software, quality assurance materials, and factory-supported installation. The complete system is designed as an integrated platform and cannot be assembled from equivalent components supplied by other manufacturers. The FACSLyric system is supported by BD FACSuite� software and integrates with BD automation products, quality control reagents, and workflow solutions to provide standardized, reproducible operation. The requested package includes proprietary components that are available only from BD Biosciences, including: � BD FACSLyric flow cytometer hardware. � BD FACSuite software and associated licenses. � Manufacturer-developed quality control and calibration procedures. � Factory installation, instrument qualification, and user training. � Manufacturer warranty, technical support, and software updates. No third-party vendor is authorized to manufacture or supply an equivalent BD FACSLyric package or provide the proprietary software, firmware, and system integration required for initial installation and validation. Substituting equipment from another manufacturer would require procurement of an entirely different analytical platform, redevelopment of laboratory workflows, retraining of personnel, and revalidation of experimental methods and quality control procedures. These changes would increase costs, delay implementation, and introduce unnecessary technical risk. Selection of another manufacturer's flow cytometer would not constitute an equivalent replacement because differences in optical configuration, detector design, software architecture, assay compatibility, and data acquisition workflows would require substantial method redevelopment and validation before producing comparable results. Notice to Interested Parties This notice is not a request for competitive quotations or proposals. However, any responsible source, including small businesses, 8(a) firms, HUBZone small businesses, service-disabled veteran-owned small businesses (SDVOSBs), women-owned small businesses (WOSBs), veteran-owned small businesses (VOSBs), and small disadvantaged businesses (SDBs), may submit a capability statement demonstrating its ability to satisfy the Government's requirement. Capability statements will be evaluated solely to determine whether a competitive procurement should be conducted. A determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the Government's discretion. Anticipated Award The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice unless the Government determines that another responsible source is capable of satisfying the Government's requirements. Capability statements must be submitted via email to haunp@mail.nih.gov no later than 9:00 a.m. EDT on August 7, 2026.
Who won similar work
10 award notices on SAM.gov in the last 24 months. Matched by: Same office (NATIONAL INSTITUTES OF HEALTH OLAO), same product/service code (PSC) 6640 and NAICS 334516.
Single-winner award sizes (10): middle half $37K to $188K, median $61K; range $21K to $230K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BRUKER NANO, INC · $BRKR · $3.0B | 1 | $230K | Aug 14, 2026 |
| Sony Biotechnology Inc. | 1 | $227K | Aug 17, 2026 |
| NEWPORT CORP | 1 | $212K | Jul 8, 2026 |
| AMUZA INC. | 1 | $115K | Jul 10, 2026 |
| PARSE BIOSCIENCES, INC. | 1 | $67K | Jul 8, 2026 |
| Mirion Technologies (Capintec), Inc. | 1 | $56K | Jun 29, 2026 |
| NIKON INSTRUMENTS INC | 1 | $40K | Sep 25, 2026 |
| SR RESEARCH LIMITED | 1 | $37K | Jul 8, 2026 |
| BECKMAN COULTER, INC | 1 | $31K | Jul 10, 2026 |
| Revvity Health Sciences, Inc. | 1 | $21K | Oct 9, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $BRKR reported $3.0B revenue in FY2025. The median single-winner award in these 10 past awards, $61K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 9, 2026Revvity Health Sciences, Inc.$21KAutomated Cell Counter and AnalyzerNo listed company matched (Materiality N/A)
- Sep 25, 2026NIKON INSTRUMENTS INC$40K66--Warming Box/Enclosure for Nikon Eclipse Ti-2 AX coNo listed company matched (Materiality N/A)
- Aug 17, 2026Sony Biotechnology Inc.$227K66--NIMH: Purchase order for One (1) Microfluidic BaseNo listed company matched (Materiality N/A)
- Aug 14, 2026BRUKER NANO, INC$230K66--NIMH: Purchase order for One (1) Miniaturized HeadMateriality: <0.01% of $BRKR revenue (Low) SEC
- Jul 10, 2026AMUZA INC.$115K66--NIMH: Purchase order for four (4) wireless fiber pNo listed company matched (Materiality N/A)
- Jul 10, 2026BECKMAN COULTER, INC$31K66--Purchase Order for two (2) Hematology AnalysersNo listed company matched (Materiality N/A)
- Jul 8, 2026SR RESEARCH LIMITED$37K66--NIMH: Purchase Order for One (1) EyeLink 1000 PlusNo listed company matched (Materiality N/A)
- Jul 8, 2026NEWPORT CORP$212K66--RFQ for One (1) Tunable Laser Multi-Photon MicroscNo listed company matched (Materiality N/A)
- Jul 8, 2026PARSE BIOSCIENCES, INC.$67K66--PO for One (1) Evercode WT v3 with UDI Plate andNo listed company matched (Materiality N/A)
- Jun 29, 2026Mirion Technologies (Capintec), Inc.$56K66--PO Three(3) Capintec CRC-55tr Dose Calibrator SystNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.